- Topic
21k Popularity
13k Popularity
99k Popularity
3k Popularity
9k Popularity
- Pin
- 📢 Exclusive on Gate Square — #PROVE Creative Contest# is Now Live!
CandyDrop × Succinct (PROVE) — Trade to share 200,000 PROVE 👉 https://www.gate.com/announcements/article/46469
Futures Lucky Draw Challenge: Guaranteed 1 PROVE Airdrop per User 👉 https://www.gate.com/announcements/article/46491
🎁 Endless creativity · Rewards keep coming — Post to share 300 PROVE!
📅 Event PeriodAugust 12, 2025, 04:00 – August 17, 2025, 16:00 UTC
📌 How to Participate
1.Publish original content on Gate Square related to PROVE or the above activities (minimum 100 words; any format: analysis, tutorial, creativ - 💙 Gate Square #Gate Blue Challenge# 💙
Show your limitless creativity with Gate Blue!
📅 Event Period
August 11 – 20, 2025
🎯 How to Participate
1. Post your original creation (image / video / hand-drawn art / digital work, etc.) on Gate Square, incorporating Gate’s brand blue or the Gate logo.
2. Include the hashtag #Gate Blue Challenge# in your post title or content.
3. Add a short blessing or message for Gate in your content (e.g., “Wishing Gate Exchange continued success — may the blue shine forever!”).
4. Submissions must be original and comply with community guidelines. Plagiarism or re - 🎉 The #CandyDrop Futures Challenge# is live — join now to share a 6 BTC prize pool!
📢 Post your futures trading experience on Gate Square with the event hashtag — $25 × 20 rewards are waiting!
🎁 $500 in futures trial vouchers up for grabs — 20 standout posts will win!
📅 Event Period: August 1, 2025, 15:00 – August 15, 2025, 19:00 (UTC+8)
👉 Event Link: https://www.gate.com/candy-drop/detail/BTC-98
Dare to trade. Dare to win.
Parataxis Holdings launched a Bitcoin-based native fund management platform in the country through the acquisition of the South Korean listed company Bridge Bio.
According to Techub News, Bitcoin investment company Parataxis Holdings LLC announced that it has reached a final investment agreement of 25 billion KRW with Bridge Biotherapeutics, Inc., which grants it control of the latter. After the transaction is completed, Bridge Biotherapeutics will be renamed Parataxis Korea and will continue to be listed on the KOSDAQ market in South Korea.
This transaction will create a Bitcoin-based native fund management platform in the South Korean public market, supported by institutional investors with rich experience in digital asset investment. As part of the transaction, Edward Chin, founder and CEO of Parataxis Holdings and co-founder and CEO of Parataxis Capital, will join the company's board of directors. Andrew Kim, partner at Parataxis Capital, will serve as the company's CEO and join the board. James Jungkue Lee, co-founder of Bridge Bio, will continue to lead the core biotechnology business and serve as a member of the company's board.